CIK Treatment for HCC Patient Underwent Radical Resection

Summary

This is a randomized controlled study. About 200 patients with hepatocellular carcinoma who underwent radical resection will be included. The patients will be randomized to group A (receive CIK treatment) or group B (just regularly follow up) without any anti-cancer treatment after resection of HCC, and the randomize ratio will be 1:1.

Timeline

Start

2008-10

Primary completion

2014-09

Completion

2014-12

Drugs

Indications